Midazolam compared with thiopentone as a hypnotic component in balanced anaesthesia: a randomized, double-blind study

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Benzodiazepines are commonly used as sedatives and hypnotics.
• Midazolam is a short-acting, water-soluble benzodiazepine derivative used for anesthesia induction.
• Balanced anesthesia involves a combination of anesthetic agents to achieve optimal patient care.

Purpose of the Study:

• To compare the efficacy and safety of midazolam versus thiopentone as hypnotic agents in balanced anesthesia.
• To evaluate parameters such as onset of action, dose response, maintenance of anesthesia, patient acceptance, amnesia, and emergence time.

Main Methods:

• Prospective, double-blind study design.
• Inclusion of 50 healthy patients undergoing short surgical procedures.
• Comparison of midazolam and thiopentone for intravenous anesthesia induction and maintenance.

Main Results:

• Thiopentone demonstrated a faster onset of action for anesthesia induction compared to midazolam.
• Midazolam provided superior maintenance of anesthesia, requiring fewer supplemental anesthetic drugs.
• Midazolam was associated with better patient acceptance and greater amnesia, with similar emergence times to thiopentone.

Conclusions:

• Midazolam is a viable alternative to thiopentone for both induction and maintenance of balanced anesthesia.
• Midazolam offers advantages in terms of anesthesia maintenance, patient acceptance, and amnesia.
• Both midazolam and thiopentone were associated with a low incidence of postoperative complications.